Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands

Author(s):
Liew, D.; Webb, K.; Meerding, W.J.; Buskens, E.; Jukema, J.W. (0000-0002-3246-8359)
Published
2012
Publication type
Article / Letter to editor
HMG-CoA reductase inhibitors (statins)Health policyDrug switchingCardiovascular diseases
Date issued
2012-05-31
Language
English
Is part of
Netherlands Heart Journal (2012), Vol. 20, no. 5, p. 197-201
hdl
1887/98331
doi
10.1007/s12471-012-0243-4